Victrex Beheer
Beheer criteriumcontroles 2/4
De CEO Victrex is James Routh, benoemd in Jan2026, heeft een ambtstermijn van minder dan een jaar. bezit rechtstreeks 0.042% van de aandelen van het bedrijf, ter waarde £ 216.46K. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 3.8 jaar en 4.3 jaar.
Belangrijke informatie
James Routh
Algemeen directeur
n/a
Totale compensatie
| Percentage CEO-salaris | n/a |
| Dienstverband CEO | less than a year |
| Eigendom CEO | 0.04% |
| Management gemiddelde ambtstermijn | 3.8yrs |
| Gemiddelde ambtstermijn bestuur | 4.3yrs |
Recente managementupdates
Recent updates
VCT: Cautious Growth And Margin Assumptions Will Shape Future P E Rerating
Analysts have lowered their price target on Victrex by £1.00, citing updates to assumptions around discount rate, revenue growth, profit margin and future P/E that collectively suggest a more balanced risk and return profile. Analyst Commentary Recent commentary around Victrex has tilted more cautious, with the latest £1.00 cut in the price target, including the 100 GBp adjustment referenced in recent research, highlighting increased focus on valuation and execution risks.
VCT: Refined Cash Flow Assumptions Will Support Future Re Rating Potential
Analysts have trimmed their price target on Victrex by £1.00, citing updated assumptions around discount rates, revenue growth, and profit margins as key drivers of the revision. Analyst Commentary JPMorgan has reduced its price target on Victrex by £1.00, reflecting refreshed assumptions around discount rates, revenue growth, and margins.
VCT: Future Upside Will Be Anchored By Resilient Earnings Framework
Analysts have trimmed their price target on Victrex by £1.00, reflecting slightly lower fair value estimates and modestly softer assumptions for revenue growth and profit margins, while still using a similar discount rate and future P/E multiple. Analyst Commentary Bullish Takeaways Bullish analysts view the £1.00 reduction in the price target as a fine tuning of fair value rather than a shift in the long term thesis, with the core assumptions on discount rate and future P/E multiple kept broadly intact.VCT: Future Upside Will Be Supported By Resilient Earnings Assumptions
Analysts have trimmed their price target for Victrex to £7.32 from £7.48. This reflects updated views on its long term fair value, discount rate, revenue growth, profit margin and future P/E assumptions.VCT: Higher Growth Assumptions Will Set Up Future Re Rating Opportunity
Analysts have trimmed their price target for Victrex to £8.90. This reflects slightly higher assumed discount and revenue growth rates, together with a small adjustment to forecast profit margins and future P/E expectations.VCT: Sector Downgrade And Lower Future P E Multiple Will Cap Rerating Potential
Analysts have trimmed their price expectations for Victrex, reflecting slightly higher discount rate assumptions, modestly different revenue growth and profit margin forecasts, and a lower future P/E multiple in light of more cautious sector views on European chemicals. Analyst Commentary Bearish analysts have taken a more cautious stance on Victrex, in line with a broader push to reduce risk within European chemicals.Does Victrex (LON:VCT) Have A Healthy Balance Sheet?
Jan 27
VCT: Sector Downgrade Will Set Up Opportunity For Future Re‑Rating
Analysts have reduced their fair value estimate for Victrex from £11.00 to £8.90, citing more cautious views on diversified chemicals and a preference for other parts of the European chemicals sector as key drivers of the updated price target assumptions. Analyst Commentary Recent research highlights a more cautious stance on diversified chemicals, with Victrex now grouped alongside peers where sentiment is restrained compared with preferred sub sectors such as industrial gases, ingredients, and distributors.Victrex (LON:VCT) Has Affirmed Its Dividend Of £0.4614
Jan 09VCT: Future Upside Will Be Driven By Resilient Earnings Power
Narrative Update Analysts have trimmed their fair value estimate for Victrex to reflect a lower price target of £9.40 from £11.00, citing a more cautious stance on European chemicals while still noting relatively steady assumptions for growth, margins and future P/E. Analyst Commentary Recent research updates on Victrex point to a more mixed stance, with some analysts maintaining a constructive view on the shares and others taking a more cautious approach to the broader European chemicals space.VCT: Sector Caution And Rating Downgrade Will Pressure Share Rerating Potential
Analysts have trimmed their fair value estimate for Victrex from £6.75 to £5.75, reflecting a slightly higher discount rate, softer medium term revenue and margin expectations, and recent price target cuts from the Street. Analyst Commentary Recent Street updates underline a more cautious stance on Victrex, with bearish analysts revising ratings and price targets lower in response to sector headwinds and company specific execution risks.Victrex (LON:VCT) Is Due To Pay A Dividend Of £0.4614
Dec 24VCT: Future Upside Will Be Driven By Medical Volume Rebound
Analysts have trimmed their price targets on Victrex, cutting the implied fair value by roughly 2 percent to reflect softer margin expectations and sector headwinds, even as they acknowledge improving revenue growth prospects along with a higher future P/E multiple. Analyst Commentary Street commentary on Victrex has become more balanced, with recent notes highlighting both improving medium term growth prospects and persistent execution risks that could cap near term upside.We Like The Quality Of Victrex's (LON:VCT) Earnings
Dec 10Victrex (LON:VCT) Has Announced A Dividend Of £0.4614
Dec 05VCT: Future Recovery Will Be Driven By Medical Volume Rebound
Victrex's analyst price targets have been revised downward, with a notable reduction from previous estimates such as 1,100 GBp to 940 GBp. Analysts cite ongoing caution towards the European chemicals sector and softer expectations for the company's recovery. Analyst Commentary Recent analyst assessments reflect a shift in sentiment towards Victrex's near-term performance and sector positioning.VCT: Future Leadership Transition Will Guide Recovery As Margins Improve
Analysts have reduced their price targets for Victrex, with consensus moving from approximately £8.77 to £8.11 per share. This reflects concerns about weaker profit margins and slower growth forecasts in the chemicals sector.Market Participants Recognise Victrex plc's (LON:VCT) Earnings
Oct 11Capital Allocation Trends At Victrex (LON:VCT) Aren't Ideal
Jun 28We Think Victrex's (LON:VCT) Healthy Earnings Might Be Conservative
May 19Victrex's (LON:VCT) Dividend Will Be £0.1342
May 15China Plant And Magma Programme Will Expand Market Reach
Initiatives like Project Vista and the new China plant aim to improve sales strategies and expand geographically, enhancing margins and growth potential.With A 31% Price Drop For Victrex plc (LON:VCT) You'll Still Get What You Pay For
Apr 08Victrex (LON:VCT) Is Finding It Tricky To Allocate Its Capital
Mar 24Are Investors Undervaluing Victrex plc (LON:VCT) By 49%?
Feb 26Victrex (LON:VCT) Is Paying Out A Dividend Of £0.4614
Jan 15Victrex plc (LON:VCT) Stocks Shoot Up 25% But Its P/E Still Looks Reasonable
Dec 06Investors Could Be Concerned With Victrex's (LON:VCT) Returns On Capital
Sep 13Shareholders Should Be Pleased With Victrex plc's (LON:VCT) Price
Aug 03Does Victrex (LON:VCT) Have A Healthy Balance Sheet?
Jul 16There Are Reasons To Feel Uneasy About Victrex's (LON:VCT) Returns On Capital
Jun 14Calculating The Fair Value Of Victrex plc (LON:VCT)
May 27Does Victrex (LON:VCT) Have A Healthy Balance Sheet?
Mar 16Returns On Capital At Victrex (LON:VCT) Paint A Concerning Picture
Feb 24Victrex plc Just Missed EPS By 5.9%: Here's What Analysts Think Will Happen Next
Jan 12Victrex (LON:VCT) Will Pay A Dividend Of £0.4614
Dec 08Investors Could Be Concerned With Victrex's (LON:VCT) Returns On Capital
Nov 23Is Victrex plc (LON:VCT) Trading At A 22% Discount?
Oct 19Is Victrex plc (LON:VCT) Potentially Undervalued?
Sep 04Victrex (LON:VCT) Could Be Struggling To Allocate Capital
Aug 17These 4 Measures Indicate That Victrex (LON:VCT) Is Using Debt Reasonably Well
Jul 22Calculating The Fair Value Of Victrex plc (LON:VCT)
Jun 30Need To Know: The Consensus Just Cut Its Victrex plc (LON:VCT) Estimates For 2023
Jun 15Is It Too Late To Consider Buying Victrex plc (LON:VCT)?
Jun 05Victrex's (LON:VCT) Dividend Will Be £0.1342
May 12CEO
James Routh (52 yo)
less than a year
Tenure
Dr. James Mathew Routh, Ph D., is Chief Executive Officer & Executive Director of Victrex plc from January 1, 2026. Dr. Routh serves as Senior Independent Non-Executive Director of Tracsis plc since Septem...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| CFO & Executive Director | 3.8yrs | UK£635.21k | 0.015% £ 79.7k | |
| CEO & Executive Director | less than a year | geen gegevens | 0.042% £ 216.5k | |
| Director of Investor Relations | 12.8yrs | geen gegevens | geen gegevens | |
| General Counsel & Company Secretary | 4.8yrs | geen gegevens | geen gegevens | |
| Group Human Resource Director | no data | geen gegevens | geen gegevens | |
| Managing Director for Medical | 2.6yrs | geen gegevens | geen gegevens | |
| Managing Director of Sustainable Solutions | no data | geen gegevens | geen gegevens |
3.8yrs
Gemiddelde duur
Ervaren management: Het managementteam van VCT wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.8 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| CFO & Executive Director | 3.8yrs | UK£635.21k | 0.015% £ 79.7k | |
| CEO & Executive Director | less than a year | geen gegevens | 0.042% £ 216.5k | |
| Independent Non-Executive Chair | 4.3yrs | UK£280.00k | 0.0080% £ 41.5k | |
| Non-Executive Director | less than a year | geen gegevens | geen gegevens | |
| Independent Non-Executive Director | 8.2yrs | UK£68.00k | 0.0021% £ 10.9k | |
| Independent Non-Executive Director | 7.9yrs | UK£70.50k | 0.0013% £ 6.9k | |
| Independent Non-Executive Director | 8.2yrs | UK£70.50k | 0.0036% £ 18.8k | |
| Senior Independent Director | 5.9yrs | UK£69.40k | 0.0022% £ 11.6k | |
| Independent Non-Executive Director | 1.9yrs | UK£58.50k | 0.00011% £ 571.8 |
4.3yrs
Gemiddelde duur
66yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van VCT wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.3 jaar).
Bedrijfsanalyse en status van financiële gegevens
| Gegevens | Laatst bijgewerkt (UTC-tijd) |
|---|---|
| Bedrijfsanalyse | 2026/04/29 13:11 |
| Aandelenkoers aan het einde van de dag | 2026/04/29 00:00 |
| Inkomsten | 2025/09/30 |
| Jaarlijkse inkomsten | 2025/09/30 |
Gegevensbronnen
De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.
| Pakket | Gegevens | Tijdframe | Voorbeeld Amerikaanse bron * |
|---|---|---|---|
| Financiële gegevens bedrijf | 10 jaar |
| |
| Consensus schattingen analisten | +3 jaar |
|
|
| Marktprijzen | 30 jaar |
| |
| Eigendom | 10 jaar |
| |
| Beheer | 10 jaar |
| |
| Belangrijkste ontwikkelingen | 10 jaar |
|
* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.
Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.
Analysemodel en Snowflake
Details van het analysemodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina. We hebben ook handleidingen over hoe je onze rapporten kunt gebruiken en tutorials op YouTube.
Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.
Industrie en sector
Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.
Bronnen van analisten
Victrex plc wordt gevolgd door 31 analisten. 12 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.
| Analist | Instelling |
|---|---|
| Gunther Zechmann | Barclays |
| Katie Richards | Barclays |
| James Stewart | Barclays |